URGENT.LY INC (ULY)

US9169311084 - Common Stock

0.5  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ULY. ULY was compared to 280 industry peers in the Software industry. Both the profitability and financial health of ULY have multiple concerns. ULY has a decent growth rate and is not valued too expensively.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

ULY had positive earnings in the past year.
In the past year ULY has reported a negative cash flow from operations.
ULY had negative earnings in 4 of the past 5 years.
ULY had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ULY's Return On Assets of 154.46% is amongst the best of the industry. ULY outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 154.46%
ROE N/A
ROIC N/A
ROA(3y)-12.82%
ROA(5y)-37.69%
ROE(3y)222.47%
ROE(5y)92.81%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of ULY (59.29%) is better than 97.85% of its industry peers.
With a Gross Margin value of 22.21%, ULY is not doing good in the industry: 84.95% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ULY has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 59.29%
GM 22.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.07%
GM growth 5YN/A

More info and screens

0

2. Health

2.1 Basic Checks

ULY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ULY has more shares outstanding
The debt/assets ratio for ULY is higher compared to a year ago.

2.2 Solvency

ULY has an Altman-Z score of -5.08. This is a bad value and indicates that ULY is not financially healthy and even has some risk of bankruptcy.
ULY's Altman-Z score of -5.08 is on the low side compared to the rest of the industry. ULY is outperformed by 85.66% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.08
ROIC/WACCN/A
WACC21.82%

2.3 Liquidity

A Current Ratio of 0.56 indicates that ULY may have some problems paying its short term obligations.
ULY has a worse Current ratio (0.56) than 92.11% of its industry peers.
ULY has a Quick Ratio of 0.56. This is a bad value and indicates that ULY is not financially healthy enough and could expect problems in meeting its short term obligations.
ULY's Quick ratio of 0.56 is on the low side compared to the rest of the industry. ULY is outperformed by 91.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 198.99% over the past year.
Looking at the last year, ULY shows a very negative growth in Revenue. The Revenue has decreased by -18.61% in the last year.
ULY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 679.41% yearly.
EPS 1Y (TTM)198.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.07%
Revenue 1Y (TTM)-18.61%
Revenue growth 3Y679.41%
Revenue growth 5YN/A
Sales Q2Q%-21.29%

3.2 Future

The Earnings Per Share is expected to grow by 26.08% on average over the next years. This is a very strong growth
ULY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.81% yearly.
EPS Next Y38.25%
EPS Next 2Y35.72%
EPS Next 3Y26.08%
EPS Next 5YN/A
Revenue Next Year-18.29%
Revenue Next 2Y-0.82%
Revenue Next 3Y5.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.12, the valuation of ULY can be described as very cheap.
Based on the Price/Earnings ratio, ULY is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of ULY to the average of the S&P500 Index (27.54), we can say ULY is valued rather cheaply.
ULY is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 0.12
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ULY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ULY's earnings are expected to grow with 26.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y35.72%
EPS Next 3Y26.08%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ULY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

URGENT.LY INC

NASDAQ:ULY (12/24/2024, 7:43:09 PM)

0.5

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners22.49%
Inst Owner Change-3.08%
Ins Owners7.65%
Ins Owner Change26.85%
Market Cap6.75M
Analysts80
Price Target1.53 (206%)
Short Float %3%
Short Ratio0.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.4%
Min EPS beat(2)-15.03%
Max EPS beat(2)-3.78%
EPS beat(4)2
Avg EPS beat(4)169.09%
Min EPS beat(4)-15.03%
Max EPS beat(4)672.65%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)-0.01%
Revenue beat(4)1
Avg Revenue beat(4)1.43%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)8.46%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)24.59%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.12
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)4.04
EY808%
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)-6.5
FCFYN/A
OCF(TTM)-6.07
OCFYN/A
SpS11.55
BVpS-1.74
TBVpS-2.37
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 154.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 59.29%
GM 22.21%
FCFM N/A
ROA(3y)-12.82%
ROA(5y)-37.69%
ROE(3y)222.47%
ROE(5y)92.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.07%
GM growth 5YN/A
F-Score5
Asset Turnover2.61
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 138.68%
Cap/Sales 3.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z -5.08
F-Score5
WACC21.82%
ROIC/WACCN/A
Cap/Depr(3y)19.88%
Cap/Depr(5y)93.64%
Cap/Sales(3y)4.85%
Cap/Sales(5y)52.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)198.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.07%
EPS Next Y38.25%
EPS Next 2Y35.72%
EPS Next 3Y26.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.61%
Revenue growth 3Y679.41%
Revenue growth 5YN/A
Sales Q2Q%-21.29%
Revenue Next Year-18.29%
Revenue Next 2Y-0.82%
Revenue Next 3Y5.81%
Revenue Next 5YN/A
EBIT growth 1Y-50.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45%
EBIT Next 3Y33.74%
EBIT Next 5YN/A
FCF growth 1Y-15.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.57%
OCF growth 3YN/A
OCF growth 5YN/A